"CARTI offers cancer care with the resources, team and technology needed to find – and treat – your cancer. From our Little Rock campus to 18 additional treatment locations across the state, CARTI makes unparalleled care accessible to all Arkansans. When it comes to cancer, we’re here for you."

During the past decade, CARTI Cancer Center conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 9 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CARTI Cancer Center" #1 sponsor was "Exact Sciences Corporation" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Novartis Pharmaceuticals" with 3 trials sponsored, "Callisto Pharmaceuticals" with 2 trials sponsored and "Helsinn Healthcare SA" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CARTI Cancer Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "CARTI" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator and "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "CARTI Cancer Center" are "Breast Cancer" (7 trials), "Multiple Myeloma" (4 trials), "Colorectal Cancer" (3 trials), "Metastatic Breast Cancer" (3 trials) and "Renal Cell Carcinoma" (3 trials). Many other conditions were trialed in "CARTI Cancer Center" in a lesser frequency.

Most popular intervention types in "CARTI Cancer Center" are "Drug" (27 trials), "Other" (7 trials), "Biological" (5 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Blood Sample Collection" (3 trials), "Placebo" (3 trials), "Atiprimod" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "CARTI Cancer Center" are 34 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "CARTI Cancer Center". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in CARTI Cancer Center, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in CARTI Cancer Center, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".

CARTI Cancer Center has several departments that took part in Clinical trials: "Little Rock Hematology Oncology Associates" - 14 trials